Form 4 for PFE Pfizer
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-25 · accession 0001225208-26-002816 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-27 | 2026-02-25+ | PFE | McDermott Michael | EVP | F - Tax | $26.94 | -40.2K | 74.3K | -35% | -$1.08M |
| D | 2026-02-27 | 2026-02-25 | PFE | McDermott Michael | EVP | M - OptEx | $33.82 | +37.9K | 114.5K | +50% | +$1.28M |
| D | 2026-02-27 | 2026-02-25 | PFE | McDermott Michael | EVP | M - OptEx | $0.00 | -37.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-25 | F | D | 36,044 | $26.92 | 77,811 | D | — | — | (F3) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F4) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| 2 | Common | Common Stock | 2026-02-25 | F | D | 679 | $27.09 | 113,855 | D | — | — | (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| 3 | Common | Common Stock | 2026-02-25 | M | A | 37,925 | $33.82 | 114,534 | D | — | — | (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| 4 | Common | Common Stock | 2026-02-26 | F | D | 3,503 | $27.10 | 74,308 | D | — | — | (F5) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |
| 5 | Derivative | Stock Appreciation Rights | 2026-02-25 | M | D | 37,925 | $0.00 | 0 | D | $33.82 · 2026-02-25 to 2026-02-25 | 37,925 Common Stock | (F6) The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |